thejoe Natures Pharmacy & Compounding Center

Natures Pharmacy & Compounding Center: 48 FDA recall reports

Every drug recall the FDA has published for Natures Pharmacy & Compounding Center. The fault, and how the agency graded it.

48Reports

0Class I

0Ongoing

2014-03-12Most recent

What the classes mean

The FDA sorts every recall into one of three classes. The class is the whole story. It is also the part people skip.

Class	What the FDA is saying
Class I	There is a reasonable probability that using this will cause serious harm or death.
Class II	It may cause temporary or reversible harm. Serious harm is unlikely.
Class III	It breaks a rule but is unlikely to hurt anyone. Often a labelling fault.

Class II is the bulk of every list here. That matters. A long list of Class II says something different from one Class I.

By class

Class	Reports
Class II	48

Checking whether it affects you

The lot or code number is what matters. Not the product name. A recall covers specific lots. Yours may not be one of them.

Check the code on your package against the report. The FDA keeps the current list at fda.gov/safety/recalls.

The reports

The text below is quoted from the FDA record word for word.

Papaverine 1nj 30mg/ml

D-1126-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Papaverine 1nj 30mg/ml
Where it went: NC

5-Fluorouracil pf in methocel 1% opthal

D-1112-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: 5-Fluorouracil pf in methocel 1% opthal
Where it went: NC

Scopolamine 0.25 opth.

D-1132-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Scopolamine 0.25 opth.
Where it went: NC

Pyridoxine (p-f) 100mg/ml

D-1129-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Pyridoxine (p-f) 100mg/ml
Where it went: NC

Methylcobalamin

D-1124-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Methylcobalamin
Where it went: NC

Papaverine 12mg/phent 1mg/Pros 9mcq/ml

D-1127-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Papaverine 12mg/phent 1mg/Pros 9mcq/ml
Where it went: NC

Ethanol 20% ophthal.

D-1110-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Ethanol 20% ophthal.
Where it went: NC

Dexamethasone (pf) 0.05 % opth.

D-1106-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Dexamethasone (pf) 0.05 % opth.
Where it went: NC

Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic

D-1107-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Dexamethosone/Tobramycin pf 0.1%/0.3% ophthalmic
Where it went: NC

Novarel (IM)

D-1125-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Novarel (IM)
Where it went: NC

EDTA 3% ophthalmic

D-1111-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: EDTA 3% ophthalmic
Where it went: NC

Bleomycin Sulfate 1unit/ml

D-1102-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Bleomycin Sulfate 1unit/ml
Where it went: NC

Voriconazole 0.5mg/ml

D-1144-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Voriconazole 0.5mg/ml
Where it went: NC

Methotrexate Intraocular 400mcg 0.1cc

D-1123-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Methotrexate Intraocular 400mcg 0.1cc
Where it went: NC

Tacrolimus 0.02% opth. (H20-based)

D-1135-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Tacrolimus 0.02% opth. (H20-based)
Where it went: NC

Vit A (olive oil) 0.1% opth.

D-1141-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Vit A (olive oil) 0.1% opth.
Where it went: NC

Folic acid (pf) 10mg/cc inj

D-1114-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Folic acid (pf) 10mg/cc inj
Where it went: NC

Triamcinolone Acetonide 3mg/ml

D-1139-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Triamcinolone Acetonide 3mg/ml
Where it went: NC

Tacrolimus (H20-based) 0.03% ophth.

D-1134-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Tacrolimus (H20-based) 0.03% ophth.
Where it went: NC

Voriconazole 1% opthal

D-1143-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Voriconazole 1% opthal
Where it went: NC

Cyanocobalamin 100mcg/ml injection

D-1103-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Cyanocobalamin 100mcg/ml injection
Where it went: NC

Cyano B-12 p-f 1000mcg/ml

D-1104-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Cyano B-12 p-f 1000mcg/ml
Where it went: NC

Sodium Bicarbonate 8.4% inj.

D-1131-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Sodium Bicarbonate 8.4% inj.
Where it went: NC

Cyano B-12 (Cmpd) 1000mcg/ml

D-1105-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Cyano B-12 (Cmpd) 1000mcg/ml
Where it went: NC

Hydroxyprogesterone Caproate

D-1121-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Hydroxyprogesterone Caproate
Where it went: NC

Tetracaine 0.5% ophth.

D-1133-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Tetracaine 0.5% ophth.
Where it went: NC

Voriconazole 0.5mg/ml

D-1145-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Voriconazole 0.5mg/ml
Where it went: NC

Lidocaine 4% Urethral Gel

D-1098-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Lidocaine 4% Urethral Gel
Where it went: NC
How much: 104 syringes

Dexamethasone phosphate 24mg/ml inj.

D-1108-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Dexamethasone phosphate 24mg/ml inj.
Where it went: NC

Glutathione Inhalation 200mg/5ml

D-1119-2014 · Class II · reported 2014-03-12 · Terminated

Why it was recalled: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product: Glutathione Inhalation 200mg/5ml
Where it went: NC

Showing the 30 most recent of 48. The rest are searchable at the FDA enforcement report database.

Read these counts with three things in mind

A firm with more recalls usually makes more products. A contract packer runs hundreds of lines. It will out-recall a company with one product whatever either does. This is not a safety ranking.

Most recalls here are voluntary. A firm found its own fault and pulled the stock. That is the system working. It lands in this database looking the same as a recall the FDA had to push for.

Terminated means the FDA considers the recall finished. It is not a verdict. It does not mean anyone was harmed.

Source: openFDA enforcement reports, retrieved 2026-08-05. FDA dataset last updated 2026-07-29.

← All drug recalls